Lilly Delivers First-Quarter 2021 Financial Results, Adjusts 2021 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Eli Lilly & Co. (LLY) Misses Q1 EPS by 27c, Lowers FY EPS Guidance
April 27, 2021 6:28 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.87, $0.27 worse than the analyst estimate of $2.14. Revenue for the quarter came in at $6.81 billion versus the consensus estimate of $7.02 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2021 EPS of $7.80-$8.00, versus the consensus of... More
